after stopping semaglutide Many Patients Maintain Weight Loss a Year and Liraglutide Weight often returns after stopping
Description
Sometimes, they are caused by a diet high in sulfur or by medications, including GLP-1s

You may verify provider and founder credentials through relevant licensing and credentialing sources if those details affect your decision

6 Obesity drugs are expanding beyond BMI reduction The therapeutic scope is moving toward comorbidity modification: type 2 diabetes prevention, glycaemic control, cardiovascular risk reduction, heart failure with preserved ejection fraction, obstructive sleep apnoea, chronic kidney disease and MASH/metabolic liver disease

Novel risk factors: obstructive sleep apnea, metabolic syndrome, left ventricular hypertrophy, left atrial enlargement

[DOI] [PMC free article] [PubMed] [Google Scholar] [162].Uldall M, Bhatt DK, Kruuse C, Juhler M, Jansen-Olesen I, Jensen RH (2017)
Starting Your GLP1 Treatment Journey Managing obesity in Prader-Willi syndrome is tough
